Discovery of Orally Active Hydroxyethylamine Based SPPL2a Inhibitors.

Saved in:
Bibliographic Details
Title: Discovery of Orally Active Hydroxyethylamine Based SPPL2a Inhibitors.
Authors: Velcicky J; Global Discovery Chemistry, and Autoimmunity Transplantation Inflammation, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland., Mathison CJN; The Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States., Nikulin V; The Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States., Pflieger D; Global Discovery Chemistry, and Autoimmunity Transplantation Inflammation, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland., Epple R; The Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States., Azimioara M; The Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States., Cow C; The Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States., Michellys PY; The Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States., Rigollier P; Global Discovery Chemistry, and Autoimmunity Transplantation Inflammation, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland., Beisner DR; The Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States., Bodendorf U; Global Discovery Chemistry, and Autoimmunity Transplantation Inflammation, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland., Guerini D; Global Discovery Chemistry, and Autoimmunity Transplantation Inflammation, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland., Liu B; The Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States., Wen B; The Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States., Zaharevitz S; The Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States., Brandl T; Global Discovery Chemistry, and Autoimmunity Transplantation Inflammation, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland.
Source: ACS medicinal chemistry letters [ACS Med Chem Lett] 2019 May 23; Vol. 10 (6), pp. 887-892. Date of Electronic Publication: 2019 May 23 (Print Publication: 2019).
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101521073 Publication Model: eCollection Cited Medium: Print ISSN: 1948-5875 (Print) Linking ISSN: 19485875 NLM ISO Abbreviation: ACS Med Chem Lett Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31223443
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Discovery of Orally Active Hydroxyethylamine Based SPPL2a Inhibitors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Velcicky+J%22">Velcicky J</searchLink>; Global Discovery Chemistry, and Autoimmunity Transplantation Inflammation, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mathison+CJN%22">Mathison CJN</searchLink>; The Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Nikulin+V%22">Nikulin V</searchLink>; The Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Pflieger+D%22">Pflieger D</searchLink>; Global Discovery Chemistry, and Autoimmunity Transplantation Inflammation, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Epple+R%22">Epple R</searchLink>; The Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Azimioara+M%22">Azimioara M</searchLink>; The Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Cow+C%22">Cow C</searchLink>; The Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Michellys+PY%22">Michellys PY</searchLink>; The Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Rigollier+P%22">Rigollier P</searchLink>; Global Discovery Chemistry, and Autoimmunity Transplantation Inflammation, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Beisner+DR%22">Beisner DR</searchLink>; The Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Bodendorf+U%22">Bodendorf U</searchLink>; Global Discovery Chemistry, and Autoimmunity Transplantation Inflammation, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Guerini+D%22">Guerini D</searchLink>; Global Discovery Chemistry, and Autoimmunity Transplantation Inflammation, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Liu+B%22">Liu B</searchLink>; The Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Wen+B%22">Wen B</searchLink>; The Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Zaharevitz+S%22">Zaharevitz S</searchLink>; The Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States.<br /><searchLink fieldCode="AU" term="%22Brandl+T%22">Brandl T</searchLink>; Global Discovery Chemistry, and Autoimmunity Transplantation Inflammation, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101521073%22">ACS medicinal chemistry letters</searchLink> [ACS Med Chem Lett] 2019 May 23; Vol. 10 (6), pp. 887-892. <i>Date of Electronic Publication: </i>2019 May 23 (<i>Print Publication: </i>2019).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101521073 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1948-5875 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219485875%22">19485875 </searchLink><i>NLM ISO Abbreviation: </i>ACS Med Chem Lett <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31223443
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1021/acsmedchemlett.9b00044
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 887
    Titles:
      – TitleFull: Discovery of Orally Active Hydroxyethylamine Based SPPL2a Inhibitors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Velcicky J
      – PersonEntity:
          Name:
            NameFull: Mathison CJN
      – PersonEntity:
          Name:
            NameFull: Nikulin V
      – PersonEntity:
          Name:
            NameFull: Pflieger D
      – PersonEntity:
          Name:
            NameFull: Epple R
      – PersonEntity:
          Name:
            NameFull: Azimioara M
      – PersonEntity:
          Name:
            NameFull: Cow C
      – PersonEntity:
          Name:
            NameFull: Michellys PY
      – PersonEntity:
          Name:
            NameFull: Rigollier P
      – PersonEntity:
          Name:
            NameFull: Beisner DR
      – PersonEntity:
          Name:
            NameFull: Bodendorf U
      – PersonEntity:
          Name:
            NameFull: Guerini D
      – PersonEntity:
          Name:
            NameFull: Liu B
      – PersonEntity:
          Name:
            NameFull: Wen B
      – PersonEntity:
          Name:
            NameFull: Zaharevitz S
      – PersonEntity:
          Name:
            NameFull: Brandl T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 05
              Text: 2019 May 23
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-print
              Value: 1948-5875
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: ACS medicinal chemistry letters
              Type: main
ResultId 1